Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ZANAMIVIR
- ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza
- Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions
- Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
- An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
- Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions
- Different Regimens in Influenza Postexposure Chemoprophylaxis in Children
- Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza
- Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
- H-IVIG Treatment for Severe H1N1 2009
- Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One
- A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
- Safety of Inhaled Zanamivir in Pregnancy
- Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
- Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand
- Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)
- A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers
- Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
- Rapid Empiric Treatment With Oseltamivir Study (RETOS)
- A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
- Relenza® Sentinel Site Monitoring Program in Japan
- Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza
- Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
- Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days
- Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir
- A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
- Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults
- Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection
- Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir
- Zanamivir Versus Trivalent Split Virus Influenza Vaccine
- A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects
Clinical trials list
click for details